Title:
併用療法
Document Type and Number:
Japanese Patent JP2023548538
Kind Code:
A
Abstract:
本明細書では、免疫細胞エンゲージャーを結合する抗体を抗体－薬物複合体と組み合わせてがんを治療する方法を提供する。【選択図】なし
Inventors:
Gardei, Shira
Smith, Allison
Klasman, Kelly
Liu, Bernardo
van epps, heather
Smith, Allison
Klasman, Kelly
Liu, Bernardo
van epps, heather
Application Number:
JP2023526901A
Publication Date:
November 17, 2023
Filing Date:
November 05, 2021
Export Citation:
Assignee:
Siegen Incorporated
International Classes:
A61K39/395; A61K31/167; A61K31/337; A61K31/395; A61K31/475; A61K31/537; A61K38/05; A61K38/06; A61K47/65; A61K47/68; A61P35/00; A61P35/02; A61P43/00; C07K16/28; C12N15/13
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office
Previous Patent: Photovoltaic devices with conductive layer interconnects
Next Patent: gripping device
Next Patent: gripping device